(Q40667947)

22 September 2017

1 reference

title

Are magnetic resonance findings predictive of clinical outcome in therapeutic trials in multiple sclerosis? The dilemma of interferon-beta (English)

1 reference

22 September 2017

McDonald WI

1

1 reference

22 September 2017

Miller DH

series ordinal

2

1 reference

22 September 2017

Thompson AJ

series ordinal

3

1 reference

22 September 2017

publication date

1 July 1994

1 reference

22 September 2017

1 reference

22 September 2017

volume

36

1 reference

22 September 2017

issue

1

1 reference

22 September 2017

page(s)

14-18

1 reference

Interferon beta-1b is effective in relapsing-remitting multiple sclerosis. II. MRI analysis results of a multicenter, randomized, double-blind, placebo-controlled trial. UBC MS/MRI Study Group and the IFNB Multiple Sclerosis Study Group

22 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FANA.410360106

Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS)

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANA.410360106

Interrater variability with the Expanded Disability Status Scale (EDSS) and Functional Systems (FS) in a multiple sclerosis clinical trial. The Canadian Cooperation MS Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANA.410360106

Multiple sclerosis: histopathologic and MR and/or CT correlation in 37 cases at biopsy and three cases at autopsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANA.410360106

Oligodendrocyte injury is an early event in lesions of multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANA.410360106

Experimental allergic encephalomyelitis and multiple sclerosis: lesion characterization with magnetization transfer imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANA.410360106

Magnetic resonance imaging of the optic nerve in optic neuritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANA.410360106

Correlation of magnetic resonance imaging with neuropsychological testing in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANA.410360106

Magnetic resonance imaging of the head in the diagnosis of multiple sclerosis: a prospective 2-year follow-up with comparison of clinical evaluation, evoked potentials, oligoclonal banding, and CT.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANA.410360106

Long‐term follow‐up of acute partial transverse myelopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANA.410360106

Systemic lymphoblastoid interferon therapy in chronic progressive multiple sclerosis. I. Clinical and MRI evaluation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANA.410360106

Epidemiology, education, and the ecology of Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANA.410360106

21 January 2018

Identifiers

DOI

10.1002/ANA.410360106

1 reference

22 September 2017

1 reference